Cargando…
Metabolic syndrome and coronary artery bypass graft surgery
Autores principales: | Brouard, M, Jimenez, JJ, Iribarren, JL, Perez, N, Lorente, L, Machado, P, Raya, JM, Perez, R, Borreguero, JM, Martinez, R, Mora, ML |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061635/ http://dx.doi.org/10.1186/cc9425 |
Ejemplares similares
-
Safety and effectiveness of different treatment regimes with tranexamic acid in elective cardiopulmonary bypass patients
por: Iribarren, JL, et al.
Publicado: (2011) -
Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
por: Jimenez, J, et al.
Publicado: (2007) -
Interaction between etomidate and beta tumoral necrosis factor on hemodynamic response after cardiac surgery
por: Iribarren, JL, et al.
Publicado: (2015) -
Preoperative left atrial dysfunction and new-onset atrial fibrillation in cardiac surgery patients
por: Brouard, M, et al.
Publicado: (2009) -
Etomidate and relative adrenal insufficiency in cardiopulmonary bypass surgery: impact on the postoperative hemodynamic status
por: Lorenzo, L, et al.
Publicado: (2008)